اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدCOVID-19: Forecasting mortality given mobility trend data and non-pharmaceutical interventions
83
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
We develop a novel hybrid epidemiological model and a specific methodology for its calibration to distinguish and assess the impact of mobility restrictions (given by Apples mobility trends data) from other complementary non-pharmaceutical interventions (NPIs) used to control the spread of COVID-19. Using the calibrated model, we estimate that mobility restrictions contribute to 47 % (US States) and 47 % (worldwide) of the overall suppression of the disease transmission rate using data up to 13/08/2020. The forecast capacity of our model was evaluated doing four-weeks ahead predictions. Using data up to 30/06/20 for calibration, the mean absolute percentage error (MAPE) of the prediction of cumulative deceased individuals was 5.0 % for the United States (51 states) and 6.7 % worldwide (49 countries). This MAPE was reduced to 3.5% for the US and 3.8% worldwide using data up to 13/08/2020. We find that the MAPE was higher for the total confirmed cases at 11.5% worldwide and 10.2% for the US States using data up to 13/08/2020. Our calibrated model achieves an average R-Squared value for cumulative confirmed and deceased cases of 0.992 using data up to 30/06/20 and 0.98 using data up to 13/08/20.
قيم البحث
اقرأ أيضاً
We present modeling of the COVID-19 epidemic in Illinois, USA, capturing the implementation of a Stay-at-Home order and scenarios for its eventual release. We use a non-Markovian age-of-infection model that is capable of handling long and variable ti
me delays without changing its model topology. Bayesian estimation of model parameters is carried out using Markov Chain Monte Carlo (MCMC) methods. This framework allows us to treat all available input information, including both the previously published parameters of the epidemic and available local data, in a uniform manner. To accurately model deaths as well as demand on the healthcare system, we calibrate our predictions to total and in-hospital deaths as well as hospital and ICU bed occupancy by COVID-19 patients. We apply this model not only to the state as a whole but also its sub-regions in order to account for the wide disparities in population size and density. Without prior information on non-pharmaceutical interventions (NPIs), the model independently reproduces a mitigation trend closely matching mobility data reported by Google and Unacast. Forward predictions of the model provide robust estimates of the peak position and severity and also enable forecasting the regional-dependent results of releasing Stay-at-Home orders. The resulting highly constrained narrative of the epidemic is able to provide estimates of its unseen progression and inform scenarios for sustainable monitoring and control of the epidemic.
Since December 2019, A novel coronavirus (2019-nCoV) has been breaking out in China, which can cause respiratory diseases and severe pneumonia. Mathematical and empirical models relying on the epidemic situation scale for forecasting disease outbreak
s have received increasing attention. Given its successful application in the evaluation of infectious diseases scale, we propose a Susceptible-Undiagnosed-Infected-Removed (SUIR) model to offer the effective prediction, prevention, and control of infectious diseases. Our model is a modified susceptible-infected-recovered (SIR) model that injects undiagnosed state and offers pre-training effective reproduction number. Our SUIR model is more precise than the traditional SIR model. Moreover, we combine domain knowledge of the epidemic to estimate effective reproduction number, which addresses the initial susceptible population of the infectious disease model approach to the ground truth. These findings have implications for the forecasting of epidemic trends in COVID-19 as these could help the growth of estimating epidemic situation.
We highlight the usefulness of city-scale agent-based simulators in studying various non-pharmaceutical interventions to manage an evolving pandemic. We ground our studies in the context of the COVID-19 pandemic and demonstrate the power of the simul
ator via several exploratory case studies in two metropolises, Bengaluru and Mumbai. Such tools become common-place in any city administrations tool kit in our march towards digital health.
When effective medical treatment and vaccination are not available, non-pharmaceutical interventions such as social distancing, home quarantine and far-reaching shutdown of public life are the only available strategies to prevent the spread of epidem
ics. Based on an extended SEIR (susceptible-exposed-infectious-recovered) model and continuous-time optimal control theory, we compute the optimal non-pharmaceutical intervention strategy for the case that a vaccine is never found and complete containment (eradication of the epidemic) is impossible. In this case, the optimal control must meet competing requirements: First, the minimization of disease-related deaths, and, second, the establishment of a sufficient degree of natural immunity at the end of the measures, in order to exclude a second wave. Moreover, the socio-economic costs of the intervention shall be kept at a minimum. The numerically computed optimal control strategy is a single-intervention scenario that goes beyond heuristically motivated interventions and simple flattening of the curve. Careful analysis of the computed control strategy reveals, however, that the obtained solution is in fact a tightrope walk close to the stability boundary of the system, where socio-economic costs and the risk of a new outbreak must be constantly balanced against one another. The model system is calibrated to reproduce the initial exponential growth phase of the COVID-19 pandemic in Germany.
Infectious diseases and human behavior are intertwined. On one side, our movements and interactions are the engines of transmission. On the other, the unfolding of viruses might induce changes to our daily activities. While intuitive, our understandi
ng of such feedback loop is still limited. Before COVID-19 the literature on the subject was mainly theoretical and largely missed validation. The main issue was the lack of empirical data capturing behavioral change induced by diseases. Things have dramatically changed in 2020. Non-pharmaceutical interventions (NPIs) have been the key weapon against the SARS-CoV-2 virus and affected virtually any societal process. Travels bans, events cancellation, social distancing, curfews, and lockdowns have become unfortunately very familiar. The scale of the emergency, the ease of survey as well as crowdsourcing deployment guaranteed by the latest technology, several Data for Good programs developed by tech giants, major mobile phone providers, and other companies have allowed unprecedented access to data describing behavioral changes induced by the pandemic. Here, I aim to review some of the vast literature written on the subject of NPIs during the COVID-19 pandemic. In doing so, I analyze 347 articles written by more than 2518 of authors in the last $12$ months. While the large majority of the sample was obtained by querying PubMed, it includes also a hand-curated list. Considering the focus, and methodology I have classified the sample into seven main categories: epidemic models, surveys, comments/perspectives, papers aiming to quantify the effects of NPIs, reviews, articles using data proxies to measure NPIs, and publicly available datasets describing NPIs. I summarize the methodology, data used, findings of the articles in each category and provide an outlook highlighting future challenges as well as opportunities
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
